medicalnewstoday.com
Applied NeuroSolutions Achieves Q2 2008 Alzheimer's Disease Serum Diagnostic Development Program Milestone
03.07.2008 09:15
medicalnewstoday.com
Applied NeuroSolutions, Inc. (OTC BB:APNS), a biotechnology Company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today announced the achievement of a key milestone directed to a multi-product program to develop serum-based diagnostic tests for Alzheimer's disease.
World
Alzheimer's Disease
Planned Parenthood Cuts Ties With Five Florida Clinics
03.07.2008 09:15
medicalnewstoday.com
Planned Parenthood Federation of America on Monday officially ended its relationship with an affiliate once known as Planned Parenthood of South Palm Beach and Broward Counties after a March review found many problems, including harassment complaints, plagiarism and possible mismanagement of nearly $450,000, the
World
Gynecology
University Health Industries Launches Natural Pet Health Care Division
03.07.2008 08:17
medicalnewstoday.com
University Health Industries Inc., (OTCBB:UVHI) a Florida corporation engaged in the development, marketing and sale of proprietary, patent-pending nutraceutical products, including its leading brands Arthroleve(TM) and Zenstral PMS(TM), announced that it is launching a new pet health care division. The pet health care division is designed to expand University Health Industries' current market focus on human health into the pet health care market.
World
Veterinary Medicine
V.A.C.(R) Therapy Clinical Study In Japan Shows Significant Efficacy In The Treatment Of Acute Wounds
03.07.2008 08:17
medicalnewstoday.com
Kinetic Concepts, Inc. (NYSE: KCI) announced that it is another step closer to introducing its V.A.C.® Therapy wound care system in Japan with the completion of a two-phase clinical study designed to determine the clinical efficacy, safety and utility of V.A.C. Therapy for wound healing in that country. Results of the study, which compared the use of V.A.C.
World
Medical Equipment
Risk Of Infection And Death Greater In Carriers Of MRSA
03.07.2008 08:17
medicalnewstoday.com
Patients harboring methicillin-resistant Staphylococcus aureus (MRSA) for long periods of time continue to be at increased risk of MRSA infection and death, according to a new study in the July 15 issue of Clinical Infectious Diseases, currently available online. MRSA is an antibiotic-resistant bacterium that can cause a variety of serious infections. The bacterium most commonly colonizes the nostrils, although it can be found in other body sites.
World
Food and Drug Administration
NanoViricides' Anti-EKC Drug Candidate To Be Studied In Japan
03.07.2008 08:17
medicalnewstoday.com
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), said that an internationally renowned Japanese ophthalmologist and corneal researcher, Kazuo Tsubota, MD, PhD, has agreed to perform confirmatory animal efficacy studies of the nanoviricide anti-EKC drug candidate, EKC-Cide™, against EKC (epidemic kerato-conjunctivitis) in Japan. Dr. Tsubota is currently Professor and Chairman of the Department of Ophthalmology at Keio University School of Medicine in Tokyo, Japan.
World
Eyesight Disorders
International Meeting To Feature Knowledge Translation Symposium
03.07.2008 08:16
medicalnewstoday.com
The mission of the International Association for Dental Research (IADR), convening here today for its 86th General Session, is to advance oral health research worldwide, and to facilitate application of its findings. A special symposium will directly address the latter by drawing attention to methodologies that can ensure the improved uptake of research knowledge through Knowledge Translation.
World
Dentistry
Fourth Annual Symposium On Liver-Directed Microsphere Therapy Raises Awareness Of The Latest Advances For Treating Metastatic Liver Tumors
03.07.2008 08:16
medicalnewstoday.com
More than 170 physicians and health care professionals specializing in the treatment of liver metastases gathered May 2-3 in Chicago for the fourth annual clinical symposium on liver-directed microsphere therapy. The symposium, sponsored by the Goshen Center for Cancer Care, was supported by an educational grant provided by Sirtex Medical. Sirtex manufactures SIR-Spheres microspheres, the only FDA-approved microsphere therapy for colorectal liver metastases.
World
Cancer
Oncolin Therapeutics Announces The Discovery Of A New More Effective Anti-Cancer Treatment In Experimental Brain Tumor Models
03.07.2008 08:16
medicalnewstoday.com
Oncolin Therapeutics, Inc., (OTCBB:OCOL) announces that a team of scientists supported by an Oncolin Sponsored Research Agreement (SRA) and lead by Professor Waldemar Priebe from The University of Texas M. D. Anderson Cancer Center (UTMDACC) has discovered a new inhibitor of glycolysis, which is superior to the other known inhibitors. These results were confirmed both in vitro as well as in vivo brain tumor models.
World
Cancer
Targeted Therapies To Lead New Wave Of Breast Cancer Treatments
03.07.2008 08:16
medicalnewstoday.com
Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life. New analysis from Frost & Sullivan, U.S.
World
Cancer
Tool To Study Complex Clusters Of Genes Developed By Texas A&M Researchers
03.07.2008 08:16
medicalnewstoday.com
Two Texas A&M University researchers have developed a computational tool that will help scientists more accurately study complex units of clustered genes, called operons, in bacteria. The tool, which allows scientists to analyze many bacterial genomes at once, is more accurate than previous methods because it starts from experimentally validated data instead of from statistical predictions, they say.
World
Biology
Enzyme Behavior Emulated By Synthetic Molecules For The First Time
03.07.2008 08:16
medicalnewstoday.com
When chemists want to produce a lot of a substance -- such as a newly designed drug -- they often turn to catalysts, molecules that speed chemical reactions. Many jobs require highly specialized catalysts, and finding one in just the right shape to connect with certain molecules can be difficult. Natural catalysts, such as enzymes in the human body that help us digest food, get around this problem by shape-shifting to suit the task at hand.
World
Biology
Study Shows Quantum Dots Can Penetrate Skin Through Minor Abrasions
03.07.2008 08:16
medicalnewstoday.com
Researchers at North Carolina State University have found that quantum dot nanoparticles can penetrate the skin if there is an abrasion, providing insight into potential workplace concerns for healthcare workers or individuals involved in the manufacturing of quantum dots or doing research on potential biomedical applications of the tiny nanoparticles.
World
Biology
Metabolomics Sheds New Light On The Question "Healthy Or Diseased?"
03.07.2008 08:16
medicalnewstoday.com
Metabolomics aims to determine the totality of all small molecules of a cell or a tissue. The exponents of bioinformatics analyzed data collected in the framework of a pre-clinical metabolomics study in healthy and diabetic mice. In each case, a subgroup of the animals was treated with the diabetes drug RoziglitazoneTM.
World
Biology
Phase II Results For Low-Dose Oral Immune Tolerance Therapy (ARG201) In Systemic Scleroderma Published
03.07.2008 08:16
medicalnewstoday.com
arGentis Pharmaceuticals, LLC announced that the Phase II results using highly purified type 1 bovine collagen orally (now known as ARG201) in the treatment of diffuse cutaneous systemic sclerosis (scleroderma - SSc) have been published in the June issue of Arthritis & Rheumatism, a major peer-reviewed rheumatology research journal.
World
Arthritis
English